Published in Thromb Haemost on September 01, 2002
Principles of care for the diagnosis and treatment of von Willebrand disease. Haematologica (2013) 1.19
Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial. Blood (2013) 1.02
Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus (2009) 0.94
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN). Haemophilia (2012) 0.91
von Willebrand's disease: a report from a meeting in the Åland islands. Haemophilia (2012) 0.89
Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage. Blood Transfus (2008) 0.84
Prophylaxis of bleeding episodes in patients with von Willebrand's disease. Blood Transfus (2008) 0.80
Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context. Clinicoecon Outcomes Res (2014) 0.78
Quantification of perioperative changes in von Willebrand factor and factor VIII during elective orthopaedic surgery in normal individuals. Haemophilia (2013) 0.77
Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study). Blood Coagul Fibrinolysis (2017) 0.75
Successful immune tolerance induction with factor VIII/von Willebrand factor concentrate in an elderly patient with severe haemophilia A and a high responder inhibitor. Blood Transfus (2010) 0.75
Human plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety data. Drugs Context (2016) 0.75
Utility of a high VWF: FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice. Blood Coagul Fibrinolysis (2015) 0.75
Towards personalised therapy for von Willebrand disease: a future role for recombinant products. Blood Transfus (2016) 0.75
Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders. J Clin Med (2017) 0.75
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A. Ther Clin Risk Manag (2016) 0.75
Treatment of patients with von Willebrand disease. J Blood Med (2011) 0.75